Research Article
Diagnostic Value of Soluble Form of Mer Tyrosine Kinase (sMerTK) in Tuberculous Pleural Effusion and Malignant Pleural Effusion
Table 3
Distribution of histological diagnoses in the MPE group and the corresponding sMerTK values.
| | | sMerTK (ng/L) |
| | Lung cancer | 51 (70.8%) | 815.79 (251.91, 2,615.01) | | Breast cancer | 5 (6.9%) | 1,347.31 (851.92, 1,744.37) | | Gastric cancer | 4 (5.6%) | 440.60 (175.24, 668.85) | | Mesothelioma of the pleura | 4 (5.6%) | 1,328.88 (603.12, 2,024.23) | | Unknown | 3 (4.2%) | 1,252.8 (592.64, 1,912.96) | | Rectal cancer | 2 (2.8%) | 446.59 (342.85, 550.33) | | Lymphoma | 2 (2.8%) | 897.26 (303.02, 1,822.23) | | Esophageal cancer | 1 (1.4%) | 834.83 |
|
|
